CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-02-23 | SCANGOS GEORGE A Chief Executive Officer | Shares withheld for taxes | −1,395 | $258.99 | $361K | 61,417 |
| 2016-02-23 | SCANGOS GEORGE A Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −2,964 | 23,586 | ||
| 2016-02-23 | SCANGOS GEORGE A Chief Executive Officer | Other disposition · Restricted Stock Unit | −5,884 | 17,702 | ||
| 2016-02-22 | Karaboutis Adriana EVP, Tech, Bus. Sol & Corp Aff | Grant or award · Restricted Stock Unit | +7,900 | 7,900 | ||
| 2016-02-22 | ALEXANDER SUSAN H EVP, Chief Legal Officer | Grant or award · Restricted Stock Unit | +7,270 | 7,270 | ||
| 2016-02-22 | Sandrock Alfred EVP CMO Neuro & Neurodegenerat | Grant or award · Restricted Stock Unit | +7,270 | 7,270 | ||
| 2016-02-22 | Artavanis-Tsakonas Spyridon SVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +6,800 | 6,800 | ||
| 2016-02-22 | DiPietro Kenneth EVP Human Resources | Grant or award · Restricted Stock Unit | +7,900 | 7,900 | ||
| 2016-02-22 | COVINO GREGORY F VP, Chief Accounting Officer | Grant or award · Restricted Stock Unit | +870 | 870 | ||
| 2016-02-22 | Clancy Paul J Executive VP and CFO | Grant or award · Restricted Stock Unit | +11,060 | 11,060 | ||
| 2016-02-22 | Cox John EVP Pharmaceutical Oper & Tech | Grant or award · Restricted Stock Unit | +11,850 | 11,850 | ||
| 2016-02-22 | SCANGOS GEORGE A Chief Executive Officer | Grant or award · Restricted Stock Unit | +40,460 | 40,460 | ||
| 2016-02-22 | Koppel Adam EVP, Strategy and Bus. Dev. | Grant or award · Restricted Stock Unit | +7,270 | 7,270 | ||
| 2016-02-17 | SCANGOS GEORGE A Chief Executive Officer | Sale | −487 | $256.16 | $125K | 59,848 |
| 2015-02-12 | SCANGOS GEORGE A Chief Executive Officer | Exercise or conversion | +9,189 | 43,466 | ||
| 2015-02-12 | SCANGOS GEORGE A Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −9,189 | 18,380 |
Page 73 of 73 · 1,456 trades